Literature DB >> 20483366

Endothelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticles.

Michael Chorny1, Elizabeth Hood, Robert J Levy, Vladimir R Muzykantov.   

Abstract

Antioxidant enzymes have shown promise as a therapy for pathological conditions involving increased production of reactive oxygen species (ROS). However the efficiency of their use for combating oxidative stress is dependent on the ability to achieve therapeutically adequate levels of active enzymes at the site of ROS-mediated injury. Thus, the implementation of antioxidant enzyme therapy requires a strategy enabling both guided delivery to the target site and effective protection of the protein in its active form. To address these requirements we developed magnetically responsive nanoparticles (MNP) formed by precipitation of calcium oleate in the presence of magnetite-based ferrofluid (controlled aggregation/precipitation) as a carrier for magnetically guided delivery of therapeutic proteins. We hypothesized that antioxidant enzymes, catalase and superoxide dismutase (SOD), can be protected from proteolytic inactivation by encapsulation in MNP. We also hypothesized that catalase-loaded MNP applied with a high-gradient magnetic field can rescue endothelial cells from hydrogen peroxide toxicity in culture. To test these hypotheses, a family of enzyme-loaded MNP formulations were prepared and characterized with respect to their magnetic properties, enzyme entrapment yields and protection capacity. SOD- and catalase-loaded MNP were formed with average sizes ranging from 300 to 400 nm, and a protein loading efficiency of 20-33%. MNP were strongly magnetically responsive (magnetic moment at saturation of 14.3 emu/g) in the absence of magnetic remanence, and exhibited a protracted release of their cargo protein in plasma. Catalase stably associated with MNP was protected from proteolysis and retained 20% of its initial enzymatic activity after 24h of exposure to pronase. Under magnetic guidance catalase-loaded MNP were rapidly taken up by cultured endothelial cells providing increased resistance to oxidative stress (62+/-12% cells rescued from hydrogen peroxide induced cell death vs. 10+/-4% under non-magnetic conditions). We conclude that non-polymeric MNP formed using the controlled aggregation/precipitation strategy are a promising carrier for targeted antioxidant enzyme therapy, and in combination with magnetic guidance can be applied to protect endothelial cells from oxidative stress mediated damage. This protective effect of magnetically targeted MNP impregnated with antioxidant enzymes can be highly relevant for the treatment of cardiovascular disease and should be further investigated in animal models. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483366      PMCID: PMC2914110          DOI: 10.1016/j.jconrel.2010.05.003

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  36 in total

1.  Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles.

Authors:  Hui-Li Ma; Xian-Rong Qi; Wu-Xiao Ding; Yoshie Maitani; Tsuneji Nagai
Journal:  J Biomed Mater Res A       Date:  2008-03-01       Impact factor: 4.396

Review 2.  Magnetic nanoparticles for drug delivery applications.

Authors:  Mini Namdeo; Sutanjay Saxena; Rasika Tankhiwale; M Bajpai; Y M Mohan; S K Bajpai
Journal:  J Nanosci Nanotechnol       Date:  2008-07

Review 3.  Current approaches to stabilising and analysing proteins during microencapsulation in PLGA.

Authors:  Christopher F van der Walle; Gaurav Sharma; Mnv Ravi Kumar
Journal:  Expert Opin Drug Deliv       Date:  2009-02       Impact factor: 6.648

Review 4.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.

Authors:  Sophie Laurent; Delphine Forge; Marc Port; Alain Roch; Caroline Robic; Luce Vander Elst; Robert N Muller
Journal:  Chem Rev       Date:  2008-06       Impact factor: 60.622

Review 5.  Synthetic carriers for vascular delivery of protein therapeutics.

Authors:  Thomas D Dziubla; Vladimir R Muzykantov
Journal:  Biotechnol Genet Eng Rev       Date:  2006

6.  Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies.

Authors:  Thomas D Dziubla; Vladimir V Shuvaev; Nan Kang Hong; Brian J Hawkins; Muniswamy Madesh; Hajime Takano; Eric Simone; Marian T Nakada; Aron Fisher; Steven M Albelda; Vladimir R Muzykantov
Journal:  Biomaterials       Date:  2007-10-24       Impact factor: 12.479

7.  Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles.

Authors:  Omid Veiseh; Jonathan W Gunn; Forrest M Kievit; Conroy Sun; Chen Fang; Jerry S H Lee; Miqin Zhang
Journal:  Small       Date:  2009-02       Impact factor: 13.281

Review 8.  Biodegradable polymeric nanocarriers for pulmonary drug delivery.

Authors:  Erik Rytting; Juliane Nguyen; Xiaoying Wang; Thomas Kissel
Journal:  Expert Opin Drug Deliv       Date:  2008-06       Impact factor: 6.648

9.  Extracellular superoxide dismutase accelerates endothelial recovery and inhibits in-stent restenosis in stented atherosclerotic Watanabe heritable hyperlipidemic rabbit aorta.

Authors:  Jan Hinrich Bräsen; Olli Leppänen; Matias Inkala; Tommi Heikura; Max Levin; Fabian Ahrens; Juha Rutanen; Hubertus Pietsch; David Bergqvist; Anna-Liisa Levonen; Samar Basu; Thomas Zeller; Günter Klöppel; Mikko O Laukkanen; Seppo Ylä-Herttuala
Journal:  J Am Coll Cardiol       Date:  2007-11-19       Impact factor: 24.094

10.  In-stent stenosis: potential role of increased oxidative stress and glutathione-linked detoxification mechanisms.

Authors:  Praphul Misra; Pratap C Reddy; Deepti Shukla; Gloria C Caldito; Lakshminarayan Yerra; Tak Y Aw
Journal:  Angiology       Date:  2008-05-25       Impact factor: 3.619

View more
  30 in total

1.  Endothelial targeting of antibody-decorated polymeric filomicelles.

Authors:  Vladimir V Shuvaev; Marc A Ilies; Eric Simone; Sergei Zaitsev; Younghoon Kim; Shenshen Cai; Abdullah Mahmud; Thomas Dziubla; Silvia Muro; Dennis E Discher; Vladimir R Muzykantov
Journal:  ACS Nano       Date:  2011-08-23       Impact factor: 15.881

Review 2.  Nanocarriers for vascular delivery of anti-inflammatory agents.

Authors:  Melissa D Howard; Elizabeth D Hood; Blaine Zern; Vladimir V Shuvaev; Tilo Grosser; Vladimir R Muzykantov
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

Review 3.  Stimuli-responsive nanocarriers for drug delivery.

Authors:  Simona Mura; Julien Nicolas; Patrick Couvreur
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

Review 4.  Magnetically targeted delivery of therapeutic agents to injured blood vessels for prevention of in-stent restenosis.

Authors:  Michael Chorny; Ilia Fishbein; Richard F Adamo; Scott P Forbes; Zoë Folchman-Wagner; Ivan S Alferiev
Journal:  Methodist Debakey Cardiovasc J       Date:  2012-01

5.  Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.

Authors:  Elizabeth D Hood; Colin F Greineder; Chandra Dodia; Jingyan Han; Clementina Mesaros; Vladimir V Shuvaev; Ian A Blair; Aron B Fisher; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2012-09-06       Impact factor: 9.776

6.  Targeted Nanocarriers for Imaging and Therapy of Vascular Inflammation.

Authors:  Ann-Marie Chacko; Elizabeth D Hood; Blaine J Zern; Vladimir R Muzykantov
Journal:  Curr Opin Colloid Interface Sci       Date:  2011-06       Impact factor: 6.448

Review 7.  Nanocarriers for vascular delivery of antioxidants.

Authors:  Elizabeth Hood; Eric Simone; Paritosh Wattamwar; Thomas Dziubla; Vladimir Muzykantov
Journal:  Nanomedicine (Lond)       Date:  2011-09       Impact factor: 5.307

Review 8.  Nanotechnology in interventional cardiology.

Authors:  Tillmann Cyrus; Samuel A Wickline; Gregory M Lanza
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-07-11

Review 9.  Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases.

Authors:  William J Kelley; Hanieh Safari; Genesis Lopez-Cazares; Omolola Eniola-Adefeso
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-05-19

Review 10.  Targeting vascular (endothelial) dysfunction.

Authors:  Andreas Daiber; Sebastian Steven; Alina Weber; Vladimir V Shuvaev; Vladimir R Muzykantov; Ismail Laher; Huige Li; Santiago Lamas; Thomas Münzel
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.